{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:07:27Z","timestamp":1794542847775,"version":"4.9.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":29,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.surg.2025.109819","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T04:21:23Z","timestamp":1760674883000},"page":"109819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["A risk-adjusted evaluation of the impact of neoadjuvant therapy on pancreatic fistula development after pancreatoduodenectomy"],"prefix":"10.1016","volume":"189","author":[{"given":"Max","family":"Judish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"Cannas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Casciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmita","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudy","family":"El Asmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Malleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Lionetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Napoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele F.","family":"Kauffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ginesini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Boggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Salvia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer H.","family":"Zureikat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Vollmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2025.109819_bib1","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.surg.2016.11.014","article-title":"The 2016 update of the international study group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after","volume":"161","author":"Bassi","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2025.109819_bib2","doi-asserted-by":"crossref","first-page":"e222","DOI":"10.1097\/SLA.0000000000003835","article-title":"Impact of complications after pancreatoduodenectomy on mortality, organ failure, hospital stay, and readmission: analysis of a nationwide audit","volume":"275","author":"Smits","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2025.109819_bib3","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/SLA.0000000000001240","article-title":"Pancreatogastrostomy versus pancreatojejunostomy for reconstruction after pancreatoduodenectomy (RECOPANC, DRKS 00000767): perioperative and long-term results of a multicenter randomized controlled trial","volume":"263","author":"Keck","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2025.109819_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znae043","article-title":"Early experience with robotic pancreatoduodenectomy versus open pancreatoduodenectomy: nationwide propensity-score-matched analysis","volume":"111","author":"de Graaf","year":"2024","journal-title":"Br J Surg"},{"key":"10.1016\/j.surg.2025.109819_bib5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11605-011-1753-x","article-title":"A root-cause analysis of mortality following major pancreatectomy","volume":"16","author":"Vollmer","year":"2012","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.surg.2025.109819_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jamcollsurg.2012.09.002","article-title":"A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy","volume":"216","author":"Callery","year":"2013","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.surg.2025.109819_bib7","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/SLA.0000000000002620","article-title":"Alternative fistula risk score for pancreatoduodenectomy (a-FRS)","volume":"269","author":"Mungroop","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2025.109819_bib8","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/SLA.0000000000003234","article-title":"Updated alternative fistula risk score (ua-FRS) to include minimally invasive pancreatoduodenectomy","volume":"273","author":"Mungroop","year":"2021","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2025.109819_bib9","article-title":"Dynamic assessment of drain fluid amylase estimates the risk of CR-POPF following pancreatoduodenectomy","author":"Al Masri","year":"2024","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2025.109819_bib10","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/SLA.0000000000005824","article-title":"Risk models for developing pancreatic fistula after pancreatoduodenectomy","volume":"278","author":"Schouten","year":"2023","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2025.109819_bib11","doi-asserted-by":"crossref","first-page":"e579","DOI":"10.1097\/MPA.0000000000002345","article-title":"Lipase-to-amylase ratio for the prediction of clinically relevant postoperative pancreatic fistula following pancreaticoduodenectomy","volume":"53","author":"Chui","year":"2024","journal-title":"Pancreas"},{"key":"10.1016\/j.surg.2025.109819_bib12","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/jso.25464","article-title":"Preoperative risk evaluation for pancreatic fistula after pancreaticoduodenectomy","volume":"119","author":"Ellis","year":"2019","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.surg.2025.109819_bib13","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1177\/00031348211047471","article-title":"Revisiting the pancreatic fistula risk score: clinical nomogram accurately assesses risk","volume":"89","author":"Mohamed","year":"2023","journal-title":"Am Surg"},{"key":"10.1016\/j.surg.2025.109819_bib14","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1097\/SLA.0000000000001832","article-title":"Multicenter, prospective trial of selective drain management for pancreatoduodenectomy using risk stratification","volume":"265","author":"McMillan","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2025.109819_bib15","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jamcollsurg.2020.01.028","article-title":"Extended experience with a dynamic, data-driven selective drain management protocol in pancreaticoduodenectomy: progressive risk stratification for better practice","volume":"230","author":"Trudeau","year":"2020","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.surg.2025.109819_bib16","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/SLA.0000000000002327","article-title":"Characterization and optimal management of high-risk pancreatic anastomoses during pancreatoduodenectomy","volume":"267","author":"Ecker","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2025.109819_bib17","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/hpb.12314","article-title":"Prophylactic octreotide for pancreatoduodenectomy: more harm than good?","volume":"16","author":"McMillan","year":"2014","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.surg.2025.109819_bib18","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.hpb.2018.03.007","article-title":"Pasireotide is not effective in reducing the development of postoperative pancreatic fistula","volume":"20","author":"Young","year":"2018","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.surg.2025.109819_bib19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11605-017-3547-2","article-title":"Pancreatogastrostomy vs pancreatojejunostomy: a risk-stratified analysis of 5316 pancreatoduodenectomies","volume":"22","author":"Ecker","year":"2018","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.surg.2025.109819_bib20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/SLA.0000000000002714","article-title":"The beneficial effects of minimizing blood loss in pancreatoduodenectomy","volume":"270","author":"Seykora","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2025.109819_bib21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10353-013-0213-0","article-title":"Gemcitabine-based neoadjuvant chemotherapy for locally advanced pancreatic cancer does not affect mortality and morbidity after pancreatic resection","volume":"45","author":"Sahora","year":"2013","journal-title":"Eur Surg"},{"key":"10.1016\/j.surg.2025.109819_bib22","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/XCS.0000000000000095","article-title":"Neoadjuvant therapy for pancreatic cancer: increased use and improved optimal outcomes","volume":"234","author":"Davis","year":"2022","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.surg.2025.109819_bib23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s11605-014-2620-3","article-title":"Does the use of neoadjuvant therapy for pancreatic adenocarcinoma increase postoperative morbidity and mortality rates?","volume":"19","author":"Cooper","year":"2015","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.surg.2025.109819_bib24","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.hpb.2021.04.027","article-title":"The effect of preoperative chemotherapy and chemoradiotherapy on pancreatic fistula and other surgical complications after pancreatic resection: a systematic review and meta-analysis of comparative studies","volume":"23","author":"van Dongen","year":"2021","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.surg.2025.109819_bib25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/jhbp.15","article-title":"Influence of preoperative anti-cancer therapy on resectability and perioperative outcomes in patients with pancreatic cancer: project study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery","volume":"21","author":"Motoi","year":"2014","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.surg.2025.109819_bib26","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jamasurg.2019.2272","article-title":"Association between pancreatic fistula and long-term survival in the era of neoadjuvant therapy","volume":"154","author":"Hank","year":"2019","journal-title":"JAMA Surg"},{"key":"10.1016\/j.surg.2025.109819_bib27","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s11605-018-3725-x","article-title":"Neoadjuvant radiation is associated with fistula formation following pancreatoduodenectomy","volume":"22","author":"Zettervall","year":"2018","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.surg.2025.109819_bib28","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/jso.26202","article-title":"Utilization of chemoradiation therapy provides strongest protective effect for avoidance of postoperative pancreatic fistula following pancreaticoduodenectomy: a NSQIP analysis","volume":"122","author":"Mangieri","year":"2020","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.surg.2025.109819_bib29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1245\/s10434-022-12257-x","article-title":"Neoadjuvant therapy versus upfront resection for nonpancreatic periampullary adenocarcinoma","volume":"30","author":"Adam","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2025.109819_bib30","doi-asserted-by":"crossref","first-page":"753","DOI":"10.6004\/jnccn.2023.0034","article-title":"Ampullary adenocarcinoma, version 1.2023, NCCN clinical practice guidelines in oncology","volume":"21","author":"Chiorean","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.surg.2025.109819_bib31","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1245\/s10434-017-5777-7","article-title":"Influence of preoperative therapy on short- and long-term outcomes of patients with adenocarcinoma of the ampulla of Vater","volume":"24","author":"Cloyd","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2025.109819_bib32","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s11605-023-05606-y","article-title":"Neoadjuvant chemotherapy for intrahepatic, perihilar, and distal cholangiocarcinoma: a National population-based comparative cohort study","volume":"27","author":"Parente","year":"2023","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.surg.2025.109819_bib33","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1097\/SLA.0000000000004068","article-title":"The fistula risk score catalog: toward precision medicine for pancreatic fistula after pancreatoduodenectomy","volume":"275","author":"Trudeau","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2025.109819_bib34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00000542-194105000-00004","article-title":"Grading of patients for surgical procedures","volume":"2","author":"Saklad","year":"1941","journal-title":"Anesthesiology"},{"key":"10.1016\/j.surg.2025.109819_bib35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2025.109819_bib36","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/00000658-199711000-00008","article-title":"Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease","volume":"226","author":"Lowy","year":"1997","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2025.109819_bib37","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1001\/jamasurg.2019.5090","article-title":"Prognostic value of pancreatic fistula in resected patients with pancreatic cancer with neoadjuvant therapy","volume":"155","author":"Trudeau","year":"2020","journal-title":"JAMA Surg"},{"key":"10.1016\/j.surg.2025.109819_bib38","doi-asserted-by":"crossref","first-page":"e527","DOI":"10.1097\/SLA.0000000000004549","article-title":"The influence of intraoperative blood loss on fistula development following pancreatoduodenectomy","volume":"276","author":"Trudeau","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2025.109819_bib39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jso.23044","article-title":"Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?","volume":"106","author":"Papalezova","year":"2012","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.surg.2025.109819_bib40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jamcollsurg.2014.02.023","article-title":"Role of neoadjuvant therapy in the multimodality treatment of older patients with pancreatic cancer","volume":"219","author":"Cooper","year":"2014","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.surg.2025.109819_bib41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3892\/mco.2020.2188","article-title":"A phase I study of preoperative (neoadjuvant) chemotherapy with gemcitabine plus nab-paclitaxel for resectable pancreatic cancer","volume":"14","author":"Tajima","year":"2021","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.surg.2025.109819_bib42","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1245\/s10434-020-08257-4","article-title":"Predictors of disease progression or performance status decline in patients undergoing neoadjuvant therapy for localized pancreatic head adenocarcinoma","volume":"27","author":"Paniccia","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2025.109819_bib43","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/jso.26589","article-title":"Optimal management of patients with operable pancreatic head cancer: a Markov decision analysis","volume":"124","author":"Rieser","year":"2021","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.surg.2025.109819_bib44","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1200\/JCO.19.02274","article-title":"Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: results of the Dutch randomized phase III PREOPANC trial","volume":"38","author":"Versteijne","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.surg.2025.109819_bib45","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znae327","article-title":"Preoperative stereotactic radiotherapy to prevent pancreatic fistula in high-risk patients undergoing pancreatoduodenectomy (FIBROPANC): prospective multicentre phase II single-arm trial","volume":"112","author":"Wismans","year":"2025","journal-title":"Br J Surg"},{"key":"10.1016\/j.surg.2025.109819_bib46","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.surg.2020.11.022","article-title":"Surgeon experience contributes to improved outcomes in pancreatoduodenectomies at high risk for fistula development","volume":"169","author":"Casciani","year":"2021","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2025.109819_bib47","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/SLA.0000000000006060","article-title":"Extending quality improvement for pancreatoduodenectomy within the high-volume setting: the experience factor","volume":"279","author":"Cannas","year":"2024","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2025.109819_bib48","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1001\/jamaoncol.2022.2319","article-title":"Efficacy of preoperative mFOLFIRINOX vs mFOLFIRINOX plus hypofractionated radiotherapy for borderline resectable adenocarcinoma of the pancreas: the A021501 phase 2 randomized clinical trial","volume":"8","author":"Katz","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.surg.2025.109819_bib49","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/jhbp.1353","article-title":"Randomized phase II trial of chemoradiotherapy with S-1 versus combination chemotherapy with gemcitabine and S-1 as neoadjuvant treatment for resectable pancreatic cancer (JASPAC 04)","volume":"30","author":"Sugiura","year":"2023","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.surg.2025.109819_bib50","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy for borderline resectable and resectable pancreatic cancer (PREOPANC-2): a multicenter randomized controlled trial","volume":"34","author":"Groot","year":"2023","journal-title":"Ann Oncol"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606025006713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606025006713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T04:27:40Z","timestamp":1780201660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606025006713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":50,"alternative-id":["S0039606025006713"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2025.109819","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A risk-adjusted evaluation of the impact of neoadjuvant therapy on pancreatic fistula development after pancreatoduodenectomy","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2025.109819","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109819"}}